|
| Rapid transitions in the standard of care for chronic lymphocytic leukemia CLL |
|
https://doi.org/10.18632/oncotarget.26826
Erlene K. Seymour
|
| 2484-2485 |
|
| The triacylglycerol, hydroxytriolein, inhibits triple negative mammary breast cancer cell proliferation through a mechanism dependent on dihydroceramide and Akt |
|
https://doi.org/10.18632/oncotarget.26824
Francisca Guardiola-Serrano, Roberto Beteta-Göbel, Raquel Rodríguez-Lorca, Maitane Ibarguren, David J. López, Silvia Terés, María Alonso-Sande, Mónica Higuera, Manuel Torres, Xavier Busquets, and Pablo V. Escribá
|
| 2486-2507 |
|
| Comparative proteomic analysis of human serum before and after liver transplantation using quantitative proteomics |
|
https://doi.org/10.18632/oncotarget.26761
Ruohan Zhang, Minglin Ou, Yue Zhang, Qiang Yan, Huaizhou Chen, Liusheng Lai, Ying Li, Feilong Xu, Donge Tang, Xuyong Sun, Jianhui Dong, Yong Dai, and Weiguo Sui
|
| 2508-2514 |
|
| Largescale insilico identification of a tumorspecific antigen pool for targeted immunotherapy in triplenegative breast cancer |
|
https://doi.org/10.18632/oncotarget.26808
Jessica Kaufmann, Nicolas Wentzensen, Titus J. Brinker, and Niels Grabe
|
| 2515-2529 |
|
| Evaluation of gilteritinib in combination with chemotherapy in preclinical models of FLT3ITD+ acute myeloid leukemia |
|
https://doi.org/10.18632/oncotarget.26811
Yoko Ueno, Masamichi Mori, Yoshiteru Kamiyama, Rika Saito, Naoki Kaneko, Eriko Isshiki, Sadao Kuromitsu, and Masahiro Takeuchi
|
| 2530-2545 |
|
| Lung cancer stem cells and their aggressive progeny controlled by EGFR/MIG6 inverse expression dictate a novel NSCLC treatment approach |
|
https://doi.org/10.18632/oncotarget.26817
Zhiguang Xiao, Bianca Sperl, Silvia Gärtner, Tatiana Nedelko, Elvira Stacher-Priehse, Axel Ullrich, and Pjotr G. Knyazev
|
| 2546-2560 |
|
| Role of surgery in gynaecological sarcomas |
|
https://doi.org/10.18632/oncotarget.26803
Valentina Ghirardi, Nicolò Bizzarri, Francesco Guida, Carmine Vascone, Barbara Costantini, Giovanni Scambia, and Anna Fagotti
|
| 2561-2575 |
|
| Correction: Monitoring EGFRT790M mutation in serum/plasma for prediction of response to thirdgeneration EGFR inhibitors in patients with lung cancer |
|
https://doi.org/10.18632/oncotarget.26855
Teresa Morán, Eudald Felip, Joaquim Bosch-Barrera, Itziar de Aguirre, Jose Luis Ramirez, Carles Mesia, Enric Carcereny, Diana Roa, Elia Sais, Yolanda GarcÃa, Remei Blanco, Silvia Sanchez, Claudia Rosa Villacorta, Cristina Queralt, Jose MarÃa Velarde, and Rafael Rosell
|
| 2576-2576 |
